Yuliya D. Vorobyeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuliya D. Vorobyeva has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Valentin V. Sytkov
Russian University of Medicine, Ministry of Health of the Russian Federation
4 shared publications - Alexey B. Danilov
Department for Nervous Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
3 shared publications - Ada R. Artemenko
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2 shared publications - Elena Glebovna Filatova
I. M. Sechenov First Moscow State Medical University (Sechenov University); Alexander Vein Headache Clinic
2 shared publications - Ivan Evgenievich Smirnov
National Medical Research Center for Children’s Health of the Ministry of Health of Russia
2 shared publications - Michail G. Rekhviashvili
Morozov Children’s City Clinical Hospital
2 shared publications
Latest Publications
- Open Access
- 31 October 2023
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 29 (1) , 20
Precision Neuronutrition: Personalized Approaches for Optimizing Brain Health
Leveraging advancements in metabolomics and other cutting-edge technologies, precision neuronutrition aims to identify personalized nutrient requirements to optimize brain health outcomes and prevent neurological disorders. The main pathological mechanisms of brain health disruption include neuroinflammation, oxidative stress, gut–brain disturbances and nutrient deficiencies. Recent studies have identified biological markers for all those mechanisms. Precision interventions for maintaining brain health and optimizing outcomes include omega-3 fatty acids, vitamin B12, vitamin D, magnesium, coenzyme q10, polyphenols, l-carnitine, prebiotics and probiotics. Precision neuronutrition offers a promising approach to optimizing brain health through personalized nutrient interventions. Continued research in this field holds great potential for improving brain health outcomes.
- 31 October 2023
- Published by MDPI AG in Biology and Life Sciences Forum
- Vol. 29 (1) , 20
Open AccessPrecision Neuronutrition: Personalized Approaches for Optimizing Brain Health
Leveraging advancements in metabolomics and other cutting-edge technologies, precision neuronutrition aims to identify personalized nutrient requirements to optimize brain health outcomes and prevent neurological disorders. The main pathological mechanisms of brain health disruption include neuroinflammation, oxidative stress, gut–brain disturbances and nutrient deficiencies. Recent studies have identified biological markers for all those mechanisms. Precision interventions for maintaining brain health and optimizing outcomes include omega-3 fatty acids, vitamin B12, vitamin D, magnesium, coenzyme q10, polyphenols, l-carnitine, prebiotics and probiotics. Precision neuronutrition offers a promising approach to optimizing brain health through personalized nutrient interventions. Continued research in this field holds great potential for improving brain health outcomes.
- Open Access
Perspectives on Neuronutrition in Prevention and Treatment of Neurological Disorders
The term neuronutrition has been proposed as part of nutritional neuroscience, studying the effects of various dietary components on behavior and cognition. Other researchers underline that neuronutrition includes the use of various nutrients and diets to prevent and treat neurological disorders. The aim of this narrative review was to explore the current understanding of the term neuronutrition as the key concept for brain health, its potential molecular targets, and perspectives of its nutritional approach to the prevention and treatment of Alzheimer’s and Parkinson’s diseases, multiple sclerosis, anxiety, depressive disorders, migraine, and chronic pain. Neuronutrition can be defined as a part of neuroscience that studies the influence of various aspects of nutrition (nutrients, diet, eating behavior, food environment, etc.) on the development of nervous disorders and includes nutrition, clinical dietetics, and neurology. There is evidence that the neuronutritional approach can influence neuroepigenetic modifications, immunological regulation, metabolic control, and behavioral patterns. The main molecular targets in neuronutrition include neuroinflammation, oxidative/nitrosative stress and mitochondrial dysfunction, gut–brain axis disturbance, and neurotransmitter imbalance. To effectively apply neuronutrition for maintaining brain health, a personalized approach is needed, which includes the adaptation of the scientific findings to the genetic, biochemical, psycho-physiological, and environmental features of each individual.
Open AccessPerspectives on Neuronutrition in Prevention and Treatment of Neurological Disorders
The term neuronutrition has been proposed as part of nutritional neuroscience, studying the effects of various dietary components on behavior and cognition. Other researchers underline that neuronutrition includes the use of various nutrients and diets to prevent and treat neurological disorders. The aim of this narrative review was to explore the current understanding of the term neuronutrition as the key concept for brain health, its potential molecular targets, and perspectives of its nutritional approach to the prevention and treatment of Alzheimer’s and Parkinson’s diseases, multiple sclerosis, anxiety, depressive disorders, migraine, and chronic pain. Neuronutrition can be defined as a part of neuroscience that studies the influence of various aspects of nutrition (nutrients, diet, eating behavior, food environment, etc.) on the development of nervous disorders and includes nutrition, clinical dietetics, and neurology. There is evidence that the neuronutritional approach can influence neuroepigenetic modifications, immunological regulation, metabolic control, and behavioral patterns. The main molecular targets in neuronutrition include neuroinflammation, oxidative/nitrosative stress and mitochondrial dysfunction, gut–brain axis disturbance, and neurotransmitter imbalance. To effectively apply neuronutrition for maintaining brain health, a personalized approach is needed, which includes the adaptation of the scientific findings to the genetic, biochemical, psycho-physiological, and environmental features of each individual.
- Open Access
- 22 February 2022
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 14 (1) , 4-13
Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines
The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders. Basic information about epidemiology, risk factors, pathophysiological mechanisms, evaluation, and the most effective pharmacological drug and non-pharmacological approaches to managing patients with medication-overuse headache are presented.
- 22 February 2022
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 14 (1) , 4-13
Open AccessEvaluation and treatment of medication-overuse headache: Russian experts’ guidelines
The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders. Basic information about epidemiology, risk factors, pathophysiological mechanisms, evaluation, and the most effective pharmacological drug and non-pharmacological approaches to managing patients with medication-overuse headache are presented.
- 18 January 2022
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 62 (1) , 4-10
Migraine and light: A narrative review
Objective: In this narrative review, we summarize clinical and experimental data on the effect of light in migraine and discuss future prospects.Background: Effective nonpharmacological treatment of hypersensitivity to light in migraine is an unmet clinical need. Current management strategies primarily consist of seeking a dark room and avoiding light exposure. Advances in the past 2 decades have improved our understanding of the underlying pathophysiology of how migraine is influenced by light. This may provide promising avenues for novel approaches in clinical management.Methods: We searched MEDLINE for articles published from database inception up to September 1, 2021. We used the search term “migraine” with the search terms “light,” “photophobia,” “treatment,” “trigger,” “circadian rhythm,” “environment,” and/or “pathophysiology.”Results: Light is commonly reported as a trigger factor of migraine attacks, however, early manifestation of photophobia and false attribution is likely the actual cause based on data deriving from retrospective, prospective, and experimental studies. The most common photophobia symptoms in migraine are exacerbation of headache by light and abnormal sensitivity to light with the underlying neural pathways likely being dependent on ongoing activity in the trigeminovascular system. Clinical studies and experimental models have identified mediators of photophobia and uncovered narrow wavebands of the light spectrum that may reduce pain intensity during a migraine attack. Consequently, novel devices have undergone exploratory clinical trials with promising results.Conclusion: False attribution is likely the reason why light is commonly reported as a trigger factor of migraine attacks, and a prospective confirmation is required to prevent unnecessary avoidance. The observation that individuals with migraine are not equally photophobic to all wavebands of the light spectrum opens the potential for innovative pain management strategies. In this context, using human‐centric lighting (also called integrative lighting) to mimic the natural daylight cycle and avoid harmful wavebands through modern technology may prove beneficial. Future research should identify direct and indirect consequences of light and other environmental factors in migraine to fill out knowledge gaps and enable evidence‐based care strategies within institutions, work environments, and other settings.
- 18 January 2022
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 62 (1) , 4-10
Migraine and light: A narrative review
Objective: In this narrative review, we summarize clinical and experimental data on the effect of light in migraine and discuss future prospects.Background: Effective nonpharmacological treatment of hypersensitivity to light in migraine is an unmet clinical need. Current management strategies primarily consist of seeking a dark room and avoiding light exposure. Advances in the past 2 decades have improved our understanding of the underlying pathophysiology of how migraine is influenced by light. This may provide promising avenues for novel approaches in clinical management.Methods: We searched MEDLINE for articles published from database inception up to September 1, 2021. We used the search term “migraine” with the search terms “light,” “photophobia,” “treatment,” “trigger,” “circadian rhythm,” “environment,” and/or “pathophysiology.”Results: Light is commonly reported as a trigger factor of migraine attacks, however, early manifestation of photophobia and false attribution is likely the actual cause based on data deriving from retrospective, prospective, and experimental studies. The most common photophobia symptoms in migraine are exacerbation of headache by light and abnormal sensitivity to light with the underlying neural pathways likely being dependent on ongoing activity in the trigeminovascular system. Clinical studies and experimental models have identified mediators of photophobia and uncovered narrow wavebands of the light spectrum that may reduce pain intensity during a migraine attack. Consequently, novel devices have undergone exploratory clinical trials with promising results.Conclusion: False attribution is likely the reason why light is commonly reported as a trigger factor of migraine attacks, and a prospective confirmation is required to prevent unnecessary avoidance. The observation that individuals with migraine are not equally photophobic to all wavebands of the light spectrum opens the potential for innovative pain management strategies. In this context, using human‐centric lighting (also called integrative lighting) to mimic the natural daylight cycle and avoid harmful wavebands through modern technology may prove beneficial. Future research should identify direct and indirect consequences of light and other environmental factors in migraine to fill out knowledge gaps and enable evidence‐based care strategies within institutions, work environments, and other settings.
- Open Access
- 1 January 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022 (1) , 1571801
Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I‐III H&Y Stage
Background. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, but the degree of this influence is underinvestigated. Particularly, impacts of the separate significant gastrointestinal symptoms, such as dyspepsia, constipation, and abdominal pain, in PD should be more precisely evaluated with the help of specific scales. Objective. To assess the impacts of gastrointestinal dysfunction and its symptoms on PD patient’s QoL using PDQ‐39. Methods. 111 PD patients in the I‐III Hoehn and Yahr (H&Y) stage were enrolled in the study. The following scales were applied: UPDRS III, PDQ‐39, GSRS, GDSS, MMSE, BDI, STAI‐S, and STAI‐T. Results. The linear regression model showed that the PDQ‐39 SI depended on summary assessments GSRS‐SI (β = 0.333, p < 0.001), BDI (β = 0.463, p < 0.001), and UPDRS III (β = 0.163, p < 0.05). The use of the stepwise method, adding GSRS‐SI and UPDRS III scores to the BDI predictor, improved the model (R2 increased from 0.454 to 0.574). The investigation of GSRS domain’s influence revealed that PDQ‐39 SI had a significant correlation with almost all of them, but the regression analysis showed significant QoL impacts of only two factors: constipation and abdominal pain (β = 0.288, p < 0.01 and β = 0.243, p < 0.05 accordingly). Conclusions. Our results suggest a considerable negative influence of depression and gastrointestinal dysfunction (especially constipation and abdominal pain) on QoL of patients with PD. Their impact on QoL in patients with I‐III H&Y stages of PD is more significant than that of motor symptoms. Therefore, the correction of depression and gastrointestinal dysfunction should be prioritized in PD therapy.
- 1 January 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022 (1) , 1571801
Open AccessGastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I‐III H&Y Stage
Background. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, but the degree of this influence is underinvestigated. Particularly, impacts of the separate significant gastrointestinal symptoms, such as dyspepsia, constipation, and abdominal pain, in PD should be more precisely evaluated with the help of specific scales. Objective. To assess the impacts of gastrointestinal dysfunction and its symptoms on PD patient’s QoL using PDQ‐39. Methods. 111 PD patients in the I‐III Hoehn and Yahr (H&Y) stage were enrolled in the study. The following scales were applied: UPDRS III, PDQ‐39, GSRS, GDSS, MMSE, BDI, STAI‐S, and STAI‐T. Results. The linear regression model showed that the PDQ‐39 SI depended on summary assessments GSRS‐SI (β = 0.333, p < 0.001), BDI (β = 0.463, p < 0.001), and UPDRS III (β = 0.163, p < 0.05). The use of the stepwise method, adding GSRS‐SI and UPDRS III scores to the BDI predictor, improved the model (R2 increased from 0.454 to 0.574). The investigation of GSRS domain’s influence revealed that PDQ‐39 SI had a significant correlation with almost all of them, but the regression analysis showed significant QoL impacts of only two factors: constipation and abdominal pain (β = 0.288, p < 0.01 and β = 0.243, p < 0.05 accordingly). Conclusions. Our results suggest a considerable negative influence of depression and gastrointestinal dysfunction (especially constipation and abdominal pain) on QoL of patients with PD. Their impact on QoL in patients with I‐III H&Y stages of PD is more significant than that of motor symptoms. Therefore, the correction of depression and gastrointestinal dysfunction should be prioritized in PD therapy.
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 16 (5) , 108-115
Irritable bowel syndrome in pediatric practice. Focus on children with a history of surgical intervention
This review aims to summarize the existing literature on irritable bowel syndrome (IBS) in children and discuss the evolution of definitions and diagnostic criteria according to the Rome IV Criteria issued in 2016. The article also covers the main theories of IBS pathogenesis, including the role of surgical interventions and changes in the intestinal microbiota. There is an overview of current therapeutic approaches used for IBS treatment in accordance with the variety of etiopathogenetic factors. It has been shown that the use of probiotics, antidepressants, prokinetics, and antispasmodics can become a strategy for the prevention and management of IBS in children. Key words: children, irritable bowel syndrome, functional gastrointestinal disorders
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 16 (5) , 108-115
Irritable bowel syndrome in pediatric practice. Focus on children with a history of surgical intervention
This review aims to summarize the existing literature on irritable bowel syndrome (IBS) in children and discuss the evolution of definitions and diagnostic criteria according to the Rome IV Criteria issued in 2016. The article also covers the main theories of IBS pathogenesis, including the role of surgical interventions and changes in the intestinal microbiota. There is an overview of current therapeutic approaches used for IBS treatment in accordance with the variety of etiopathogenetic factors. It has been shown that the use of probiotics, antidepressants, prokinetics, and antispasmodics can become a strategy for the prevention and management of IBS in children. Key words: children, irritable bowel syndrome, functional gastrointestinal disorders
- Open Access
- 3 July 2020
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 23 (3)
Multidisciplinary approach in the treatment of a newborn child with chylotorax
Chylothorax in children is a fairly rare but at the same time serious pathology. Accumulation of a large amount of fluid in the pleural cavity leads to the development of respiratory, cardiovascular failure, and even death. In some children, this process can be initiated even before birth. The main components in the treatment of chylothorax are as follows: conservative measures aimed at reducing the amount of chyle, paracentesis, and drainage of the pleural cavity, mini-invasive surgery. To date, universal approaches to the management of patients with chylothorax have not been fully developed, there are no common diagnostic algorithms, terms, and optimal treatment tactics. There are only a few publications on this issue in literature, which are descriptive in nature and based on a small number of observations. The low prevalence of chylothorax in newborn infants, different etiology, various pathogenetic mechanisms of the disease make it difficult to conduct large-scale randomized trials in this area that would fully meet the modern requirements of evidence-based medicine. In this article, the authors demonstrate a multidisciplinary approach to treating a child with congenital chylothorax.
- 3 July 2020
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 23 (3)
Open AccessMultidisciplinary approach in the treatment of a newborn child with chylotorax
Chylothorax in children is a fairly rare but at the same time serious pathology. Accumulation of a large amount of fluid in the pleural cavity leads to the development of respiratory, cardiovascular failure, and even death. In some children, this process can be initiated even before birth. The main components in the treatment of chylothorax are as follows: conservative measures aimed at reducing the amount of chyle, paracentesis, and drainage of the pleural cavity, mini-invasive surgery. To date, universal approaches to the management of patients with chylothorax have not been fully developed, there are no common diagnostic algorithms, terms, and optimal treatment tactics. There are only a few publications on this issue in literature, which are descriptive in nature and based on a small number of observations. The low prevalence of chylothorax in newborn infants, different etiology, various pathogenetic mechanisms of the disease make it difficult to conduct large-scale randomized trials in this area that would fully meet the modern requirements of evidence-based medicine. In this article, the authors demonstrate a multidisciplinary approach to treating a child with congenital chylothorax.
- Open Access
- 3 July 2020
- Published by Springer Nature in Pain and Therapy
- Vol. 9 (2) , 411-425
Sleep Disorders and Headache: A Review of Correlation and Mutual Influence
The review is devoted to the complex relationship between headache and sleep disorders. The shared neuroanatomical structures of the nervous system involved in pain perception and sleep are shown, and mechanisms of comorbidity between headaches and sleep disorders are considered. Various types of headaches in the continuum of the sleep–wake cycle are described. Both pharmacological and non-pharmacological approaches to treatment are examined in detail, with the biochemical basis of the drug action.
- 3 July 2020
- Published by Springer Nature in Pain and Therapy
- Vol. 9 (2) , 411-425
Open AccessSleep Disorders and Headache: A Review of Correlation and Mutual Influence
The review is devoted to the complex relationship between headache and sleep disorders. The shared neuroanatomical structures of the nervous system involved in pain perception and sleep are shown, and mechanisms of comorbidity between headaches and sleep disorders are considered. Various types of headaches in the continuum of the sleep–wake cycle are described. Both pharmacological and non-pharmacological approaches to treatment are examined in detail, with the biochemical basis of the drug action.
- Open Access
- 27 March 2020
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 23 (1)
MODERN METHODS FOR DIAGNOSING PATHOLOGY OF THE CARDIO-ESOPHAGEAL TRANSITION IN CHILDREN
The pathology of the esophagus is diverse, therefore, disorders of the structural and functional state of the esophagus require different approaches both in the diagnosis of its pathology and in treatment. The review presents data on innovative diagnostic methods for the pathology of the cardio-esophageal transition in pediatric patients. The methods used were literature search in the databases PubMed, Medlit, RSCI, Scopus, Web of Science, EMBASE. Modern ideas about the neurophysiology of the gastroesophageal transition, the mechanisms of its antireflux function, and the pathogenesis of various pathologies of this anatomical localization, mainly gastroesophageal reflux disease (GERD), are described in both infants and school children. The features of the clinical picture of GERD depending on the age of the patient and the nature of the reflux agent are presented. The phenotypes of reflux disease are determined. The characteristics and modifications of existing original methods for studying the cardio-esophageal transition (both their advantages and disadvantages) are described in detail. The approaches to the possible optimization of management of this group of patients are proposed.
- 27 March 2020
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 23 (1)
Open AccessMODERN METHODS FOR DIAGNOSING PATHOLOGY OF THE CARDIO-ESOPHAGEAL TRANSITION IN CHILDREN
The pathology of the esophagus is diverse, therefore, disorders of the structural and functional state of the esophagus require different approaches both in the diagnosis of its pathology and in treatment. The review presents data on innovative diagnostic methods for the pathology of the cardio-esophageal transition in pediatric patients. The methods used were literature search in the databases PubMed, Medlit, RSCI, Scopus, Web of Science, EMBASE. Modern ideas about the neurophysiology of the gastroesophageal transition, the mechanisms of its antireflux function, and the pathogenesis of various pathologies of this anatomical localization, mainly gastroesophageal reflux disease (GERD), are described in both infants and school children. The features of the clinical picture of GERD depending on the age of the patient and the nature of the reflux agent are presented. The phenotypes of reflux disease are determined. The characteristics and modifications of existing original methods for studying the cardio-esophageal transition (both their advantages and disadvantages) are described in detail. The approaches to the possible optimization of management of this group of patients are proposed.
- 1 January 2020
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 15 (4)
Principles of rational antibacterial preventive therapy in children after colorectal surgery
This article focuses on the most important issues of perioperative antimicrobial prophylaxis (PAP) in pediatric colorectal surgery. We have analyzed currently available Russian and foreign documents on PAP and its specific characteristics in pediatric practice and colorectal surgery. We have provided the most up-to-date recommendations on perioperative prevention of enterocolitis and strictures in children with Hirschsprung's disease. Key words: antibacterial preventive therapy, colorectal surgery, pediatric surgery, surgical wound infection
- 1 January 2020
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 15 (4)
Principles of rational antibacterial preventive therapy in children after colorectal surgery
This article focuses on the most important issues of perioperative antimicrobial prophylaxis (PAP) in pediatric colorectal surgery. We have analyzed currently available Russian and foreign documents on PAP and its specific characteristics in pediatric practice and colorectal surgery. We have provided the most up-to-date recommendations on perioperative prevention of enterocolitis and strictures in children with Hirschsprung's disease. Key words: antibacterial preventive therapy, colorectal surgery, pediatric surgery, surgical wound infection